Epidemiology of extended-spectrum β-lactamase producing Escherichia coli in the stools of returning Japanese travelers, and the risk factors for colonization

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Yaita, Kenichiro ^a   Aoki, Kotaro ^b   Suzuki, Takumitsu ^a   Nakaharai, Kazuhiko ^a   Yoshimura, Yukihiro ^a   Harada, Sohei ^c   Ishii, Yoshikazu ^b   Tachikawa, Natsuo ^a  

^a YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METALLO BETA LACTAMASE; BETA LACTAMASE; BETA-LACTAMASE CTX-M-15;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; GENE SEQUENCE; HUMAN; INDIA; INFECTION PREVENTION; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; RISK FACTOR; SCREENING TEST; TRAVEL; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GENETICS; ISOLATION AND PURIFICATION; JAPAN; MICROBIOLOGY; MIDDLE AGED; TRANSMISSION;

ADULT; BETA-LACTAMASES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; TRAVEL;

EID: 84901318431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098000     Document Type: Article

References (30)

1. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD (2008) Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57: 441-448.
2. Tham J, Walder M, Melander E, Odenholt I (2012) Duration of colonization with extended-spectrum β-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis 44: 573-577.
3. Walsh TR, Weeks J, Livermore DM, Toleman MA (2011) Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 11: 355-362.
4. Hawkey PM (2008) Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 14 Suppl 1: 159-165.
5. Woodford N (2011) Unwanted souvenirs travel and multi-resistant bacteria. J Travel Med 18: 297-298.
6. Donnenberg MS (2009) Enterobactriacae. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone. 2815-2833.
7. Clinical and Laboratory Standards Institute (2011) Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically. CLSI document M7-A9. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
8. Clinical and Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania.
9. Kimura S, Ishii Y, Yamaguchi K. (2005) Evaluation of dipicolinic acid for detection of IMP- or VIM- type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis. 53: 241-244. (Pubitemid 41607631)
10. Xu L, Ensor V, Gossain S, Nye K, Hawkey P (2005) Rapid and simple detection of blaCTX-M genes by multiplex PCR assay. J Med Microbiol. 54: 1183-1187. (Pubitemid 41783826)
11. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, et al. (2002) Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209: 161-168. (Pubitemid 34465587)
12. Tritt A, Eisen JA, Facciotti MT, Darling AE (2012) An integrated pipeline for de novo assembly of microbial genomes. PLoS One. 7: e42304.
13. Kanda Y (2012) Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 1-7.
14. Tängdén T, Cars O, Melhus A, Löwdin E (2010) Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extendedspectrum β-lactamases a prospective study with Swedish volunteers. Antimicrob Agents Chemother 54: 3564-3568.
15. Peirano G, Laupland KB, Gregson DB, Pitout JD (2011) Colonization of Returning Travelers With CTX-M-Producing Escherichia coli. J Travel Med 18: 299-303.
16. Weisenberg SA, Mediavilla JR, Chen L, Alexander EL, Rhee KY, et al. (2012) Extended spectrum β-lactamase-producing enterobacteriaceae in international travelers and non-travelers in New York City. PLoS One 7: e45141.
17. Ostholm-Balkhed A, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, et al. (2013) Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae incidence and risk factors. J Antimicrob Chemother 68: 2144-2153.
18. Luvsansharav UO, Hirai I, Niki M, Nakata A, Yoshinaga A, et al. (2011) Prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among healthy adult people in Japan. J Infect Chemother 17: 722-725.
19. Islam S (2012) High rates of ESBL-producing Escherichia coli in young children who traveled recently to India. Pediatr Infect Dis J 31: 1103.
20. Freeman JT, McBride SJ, Heffernan H, Bathgate T, Pope C, et al. (2008) Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian subcontinent in New Zealand. Clin Infect Dis 47: 689-692.
21. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, et al. (2009) Emergence of high levels of extended-spectrum-β-lactamase-producing Gramnegative bacilli in the Asia-Pacific region data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 53: 3280-3284.
22. Brink AJ, Botha RF, Poswa X, Senekal M, Badal RE, et al. (2012) Antimicrobial susceptibility of Gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009) impact of the new carbapenem breakpoints. Surg Infect (Larchmt) 13: 43-49.
23. Deresinski S (2011) Travels with ESBLs. Clin Infect Dis 52: iii-iv.
24. Ensor VM, Shahid M, Evans JT, Hawkey PM (2006) Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58: 1260-1263. (Pubitemid 44884149)
25. Chong Y, Yakushiji H, Ito Y, Kamimura T (2011) Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 30: 83-87.
26. Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, et al. (2006) PCR classification of CTX-M-type β-lactamase genes identified in clinically isolated Gram-negative bacilli in Japan. Antimicrob Agents Chemother 50: 791-795. (Pubitemid 43191004)
27. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, et al. (2009) Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63: 72-79.
28. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, et al. (2008) Dissemination of clonally related Escherichia coli strains expressing extended-spectrum blactamase CTX-M-15. Emerg Infect Dis 14: 195-200. (Pubitemid 351213667)
29. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 273-281.
30. Pitout JD, Campbell L, Church DL, Gregson DB, Laupland KB (2009) Molecular characteristics of travel-related extended-spectrum-β- lactamaseproducing Escherichia coli isolates from the Calgary Health Region. Antimicrob Agents Chemother 53: 2539-2543.